Weight stagnation under Mounjaro is a frequent and predictable phenomenon. Understanding its mechanisms allows it to be overcome.
After several months of regular weight loss with tirzepatide, many patients reach a plateau: weight stabilizes despite continued treatment and dietary efforts. This phenomenon, a source of frustration and discouragement, is in reality a normal physiological response of the body. Here’s how to understand and overcome it.
Why does the plateau occur?
The weight loss plateau results from a set of adaptive mechanisms that the body implements to counteract mass loss:
- Reduction in basal metabolism: for every kg lost, resting metabolism decreases by approximately 7 kcal/day. After 20 kg of loss, this represents 140 kcal/day less
- Hormonal adaptation: increase in ghrelin (hunger hormone) and decrease in leptin (satiety hormone)
- Reduction in diet-induced thermogenesis: the body becomes more efficient in energy utilization
- Decrease in activity-related energy expenditure: a lighter body expends less energy for the same movements
- Restored caloric balance: calories consumed eventually equal calories expended at the new weight
When does the plateau typically occur?
With tirzepatide, the plateau generally occurs between the 9th and 15th month of treatment. This timing corresponds to the phase where weight loss begins to slow significantly in the SURMOUNT study curves. At the maximum dose of 15 mg, patients achieve approximately 80-90% of their maximum weight loss around the 9th month, with the last 10-20% being acquired more slowly.
It is important to distinguish a true plateau (stagnation for 4 weeks or more despite adequate adherence) from normal weight fluctuations (variations of 1-2 kg related to hydration, menstrual cycle, or digestive content).
Strategies to overcome the plateau
Several evidence-based approaches can help restart weight loss:
- Dose increase: if you are not yet at the maximum dose (15 mg), your doctor may consider an increase. Each dose escalation offers additional benefit
- Dietary plan revision: recalculate your caloric needs at the new weight and adjust accordingly. A deficit of 300-500 kcal/day is recommended
- Exercise intensification: add strength training to boost basal metabolism, or vary exercise types to challenge the body
- Increased protein intake: aim for 1.5 g/kg of target weight to maximize satiety and diet-induced thermogenesis
- Stress and sleep management: chronically elevated cortisol and lack of sleep promote fat storage
- Strategic patience: sometimes, maintaining the course for 4-8 weeks is enough for the body to adapt and for weight loss to resume
What not to do
Certain reactions to a plateau are counterproductive:
- Drastically reduce calories: too large a deficit (< 1200 kcal/day) further slows metabolism
- Stop treatment: discontinuation systematically leads to weight regain (SURMOUNT-4 data)
- Double the dose without medical advice: dangerous and ineffective in the long term
- Weigh yourself multiple times a day: a source of unnecessary anxiety; weighing once a week in the morning on an empty stomach is sufficient
Regular monitoring of your weight and habits is essential to identify a true plateau and adjust your strategy. The MounjaGO application helps you visualize your weight curve over the long term and detect trends beyond daily fluctuations.
FAQ: Weight Loss Plateau
My weight has been stagnant for 2 weeks, is this a plateau?
Not necessarily. Weight fluctuations over 1-2 weeks are normal. A plateau is considered to be 4 weeks or more of stagnation or regain despite adequate adherence to treatment and recommendations.
Does a plateau mean Mounjaro is no longer working?
No. A plateau is a normal metabolic response, not a sign of treatment ineffectiveness. Tirzepatide continues to act on your GLP-1 and GIP receptors. It’s your metabolism that has adapted to your new weight.
Should I change treatment if I’m stagnant?
Not necessarily. The strategies mentioned above are sufficient in most cases. If the plateau persists despite these adjustments, your doctor may consider a combination medication or a thorough metabolic assessment.